U.S. markets closed

Verastem, Inc. (VSTM)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.2500-0.0300 (-2.34%)
At close: 4:00PM EDT

1.2400 -0.01 (-0.80%)
After hours: 5:14PM EDT

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected


Previous Close1.2800
Bid1.2500 x 45900
Ask1.2700 x 21500
Day's Range1.2400 - 1.3050
52 Week Range0.8300 - 4.6700
Avg. Volume3,771,100
Market Cap211.915M
Beta (5Y Monthly)0.72
PE Ratio (TTM)N/A
EPS (TTM)-1.2250
Earnings DateAug 10, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est3.83
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Hedge Funds Are Getting More Bullish On Verastem Inc (VSTM)
    Insider Monkey

    Hedge Funds Are Getting More Bullish On Verastem Inc (VSTM)

    Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds’ and successful investors’ positions as of the end of the second quarter. You can find articles about an individual hedge fund’s trades on numerous financial […]

  • Verastem (VSTM) Jumps: Stock Rises 7.1%

    Verastem (VSTM) Jumps: Stock Rises 7.1%

    Verastem (VSTM) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.

  • Business Wire

    Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    Verastem, Inc. (Nasdaq:VSTM) (also known as Verastem Oncology), a biopharmaceutical company committed to advancing new medicines for patients battling cancer, today announced the grant of options to purchase 39,000 shares of its common stock to three new employees and the grant of 22,500 restricted stock units (RSUs) to two of the three new employees. The awards were granted as an inducement material to the employees' acceptance of employment with Verastem Oncology in accordance with Nasdaq Listing Rule 5635(c)(4). The options have an exercise price equal to $1.26 per share, the closing price of Verastem Oncology's common stock as reported by Nasdaq on October 1, 2020. The stock options and RSUs that were granted to the three new employees will vest at a rate of twenty-five percent (25%) on the one year anniversary of the employee's date of hire, with the remaining shares vesting quarterly over the next three (3) years in equal quarterly amounts, provided the employees continue to serve as employees of or other service providers to Verastem Oncology on each such vesting date.